(Q37535507)

20 August 2017

1 reference

title

Familial pituitary tumor syndromes (English)

1 reference

20 August 2017

4

Bruce G Robinson

1 reference

20 August 2017

Marianne S Elston

1

1 reference

20 August 2017

Kerrie L McDonald

series ordinal

2

1 reference

20 August 2017

Roderick J Clifton-Bligh

series ordinal

3

1 reference

20 August 2017

publication date

30 June 2009

1 reference

Nature Reviews Endocrinology

20 August 2017

published in

1 reference

20 August 2017

volume

5

1 reference

20 August 2017

issue

8

1 reference

20 August 2017

page(s)

453-461

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2009.126

20 August 2017

exact match

0 references

cites work

The complex of myxomas, spotty pigmentation, and endocrine overactivity

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

The prevalence of pituitary adenomas: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Positional cloning of the gene for multiple endocrine neoplasia-type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Mutation and cancer: statistical study of retinoblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Clinical studies of multiple endocrine neoplasia type 1 (MEN1)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Multiple Endocrine Neoplasia Type 1: A 10-Year Prospective Screening Study in Four Kindreds*

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Multiple endocrine neoplasia type 1: new clinical and basic findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Results of treatment of pituitary disease in multiple endocrine neoplasia, type I.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Multiple endocrine neoplasia type 1-associated thyrotropin-producing pituitary carcinoma: report of a probable de novo example

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Acromegaly caused by growth hormone-relating hormone in a patient with multiple endocrine neoplasia type I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Reversible sellar enlargement due to growth hormone-releasing hormone production by pancreatic endocrine tumors in a acromegalic patient with multiple endocrine neoplasia type I syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Menin, the product of the MEN1 gene, is a nuclear protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

In search of tumor suppressing functions of menin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Transfection of the multiple endocrine neoplasia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of JunD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen, and QM/

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Stable overexpression of MEN1 suppresses tumorigenicity of RAS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Multiple tumor suppressor pathways negatively regulate telomerase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Clinical Testing for Mutations in theMEN1Gene in Sweden: A Report on 200 Unrelated Cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Germline MEN1 mutations in sixteen Japanese families with multiple endocrine neoplasia type 1 (MEN1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Gene diagnosis and clinical management of multiple endocrine neoplasia type 1 (MEN1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Prevalence of MEN 1 in patients with prolactinoma. MEN1 Study Group of the Hospital de la Santa Creu i Sant Pau of Barcelona

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Primary adrenocortical nodular dysplasia with Cushing's syndrome and cardiac myxomas. A peculiar familial disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Carney complex: the first 20 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Ductal adenoma of the breast with tubular features. A probable component of the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Genetic heterogeneity of familial atrial myxoma syndromes (Carney complex)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Carney complex: pathology and molecular genetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Neurosurgical implications of Carney complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Pituitary pathology in patients with Carney Complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

A mouse model for Carney complex.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

The clinical, pathological, and genetic features of familial isolated pituitary adenomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Pituitary adenoma predisposition caused by germline mutations in the AIP gene.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Large genomic deletions in AIP in pituitary adenoma predisposition.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Mutations in theAryl Hydrocarbon Receptor Interacting ProteinGene Are Not Highly Prevalent among Subjects with Sporadic Pituitary Adenomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

AIP Mutations are not Identified in Patients with Sporadic Pituitary Adenomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Aryl hydrocarbon receptor interacting protein(AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Defining the role for XAP2 in stabilization of the dioxin receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.126

Somatic mutations in MEN type 1 tumors, consistent with the Knudson "two-hit" hypothesis

31 March 2020

1 reference

12 December 2020

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

1 reference

12 December 2020

Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.

1 reference

12 December 2020

Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland

1 reference

12 December 2020

Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred

1 reference

12 December 2020

Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1

1 reference

12 December 2020

Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study

1 reference

12 December 2020

Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex).

1 reference

12 December 2020

Pituitary adenomas of the multiple endocrine neoplasia type I syndrome

1 reference

12 December 2020

Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries

1 reference

12 December 2020

1 reference

12 December 2020

Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland

1 reference

12 December 2020

Metastatic prolactinoma presenting as a cervical spinal cord tumour in multiple endocrine neoplasia type one (MEN-1)

1 reference

12 December 2020

The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2009.126

1 reference

Dimensions Publication ID

20 August 2017

1017784981

0 references

1 reference